Icon
+91 94997 68112
Login Register

VISTIDE (nda020638)- (EQ 75MG BASE/ML)

CIDOFOVIR GILEAD SCIENCES INC
EQ 75MG BASE/ML
No No
2010-Jun-26 Expired
None None
None No
Vistide is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS).
2 0 2
Total Other Developers None
Drugs with Suitability No
EQ 75MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ************* ***** ******** *********** *******, ** ******, , ******* (***) ***
****** **** ************ ***** ****** ******* ******* *********** ** **, ****** ********** *******, ***** *, *****, ********* ******, ***** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.